This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Chugai Seiyaku Kabushiki Kaisha, Genentech, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2023
Title: Kenji Adachi: Innovator in Cancer Treatment
Introduction
Kenji Adachi is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on utilizing advanced methods to combat cancer effectively.
Latest Patents
Kenji Adachi holds 1 patent for his invention titled "Methods of treating cancers using PD-1 axis binding antagonists and anti-GPC3 antibodies." This invention provides compositions and methods for treating cancers by administering a PD-1 axis binding antagonist alongside an anti-GPC3 antibody. The pharmaceutical compositions developed by Adachi are designed to enhance the efficacy of cancer treatments.
Career Highlights
Throughout his career, Kenji Adachi has worked with notable companies in the pharmaceutical industry, including Chugai Seiyaku Kabushiki Kaisha and Genentech, Inc. His experience in these organizations has allowed him to refine his expertise in cancer research and treatment methodologies.
Collaborations
Kenji Adachi has collaborated with several professionals in his field, including Mika Endo and Atsuhiko Kato. These collaborations have contributed to the advancement of his research and the development of innovative cancer treatment solutions.
Conclusion
Kenji Adachi's contributions to cancer treatment through his patented methods highlight his role as an influential inventor in the medical field. His work continues to pave the way for new therapeutic approaches in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile